New research found that differences in carbohydrate quality can impact weight management in middle-aged adults. Participants whose carb intake included more starch and added sugar saw more weight gain as time progressed; participants whose carb intake boosted their dietary fiber intake saw less weight gain.
Drugs like Ozempic can boost the risk of some gastrointestinal problems in weight loss patients, compared to other weight loss drugs, a study has revealed for the first time but the risk remains low.
People taking popular medications like Ozempic, Wegovy, and Rybelsus for weight loss are at higher risk of potentially serious stomach and intestinal issues, compared to people taking a weight loss drug approved in 2014, a large study reveals.